Spectrascience New (SCIE) 0.0180 $SCIE
SpectraScience Announces Business Update Conference Call
GlobeNewswire - Tue Aug 19, 3:01PM CDT
SpectraScience, Inc. (OTCQB:SCIE) today announced the Company will hold a conference call at 4:30 p.m. Eastern (1:30 p.m. Pacific) on August 26, 2014 to provide an update on its business.
Volvo completes divestiture of Volvo Rents for USD1.1bn
M2 - Tue Feb 04, 6:02AM CST
Volvo AB (STO: VOLVA), based in Sweden, announced on Monday that its divestiture of Volvo Rents was completed on 31 January 2014.
SpectraScience Announces Commencement of Pan-European MORDIS Evaluation on WavSTAT4
GlobeNewswire - Mon Aug 05, 8:00AM CDT
SpectraScience, Inc. (OTCQB:SCIE), a San Diego-based medical device company, announced today that it has begun submission of its protocol to participating institutions for the MORDIS (MOdified Resect and DIScard) evaluation. The evaluation, which will be conducted at eight sites across Europe, brings together the foremost gastroenterologists in each of the respective nations to once again validate the clinical efficacy of the WavSTAT4 Optical Biopsy System.
SpectraScience Inc anticipates Q2 2013 revenues of USD120,000
M2 - Fri Jun 28, 7:31AM CDT
Medical device company SpectraScience Inc (OTCQB:SCIE) said on Thursday that it expects to generate revenues of approximately USD120,000 for its Q2 ending 30 June 2013.
SpectraScience Announces Q2 2013 Revenue
Marketwire - Thu Jun 27, 8:01AM CDT
SpectraScience, Inc. (OTCQB: SCIE), a San Diego-based medical device company, today announced it expects to recognize revenue of approximately $120,000 for its second quarter ending June 30, 2013.
SpectraScience, Inc. Announces Minimum Purchase Agreement With PENTAX Medical
Marketwire - Mon Jun 24, 8:01AM CDT
SpectraScience, Inc. (OTCQB: SCIE) announced today that PENTAX Medical GmbH, the sales, marketing and distribution partner for the WavSTAT4 Optical Biopsy System in Europe, has finalized and signed the minimum purchase requirement Exhibit of the Distribution Agreement for their fiscal year ending March 2014.
SpectraScience, Inc. Announces WavSTAT Live Demonstration at GEEW in Brussels
Marketwire - Wed Jun 19, 8:00AM CDT
SpectraScience, Inc. (OTCQB: SCIE) announced today that its WavSTAT4 Optical Biopsy System is being demonstrated at the 31(st) annual Gastroenterology and Endotherapy European Workshop (GEEW) that is taking place from Monday, June 17, through Wednesday, June 19, 2013 at the Brussels Exhibition Centre Hall 10 and Auditorium 2000 in Brussels, Belgium.
SpectraScience, Inc. Announces Positive Results From Study by Dr. Helmut Neumann
Marketwire - Tue Jun 11, 8:02AM CDT
SpectraScience, Inc. (OTCQB: SCIE) announced today that results from a critical study conducted by Dr. Helmut Neumann, of the University of Elrangen - Nuremberg in Erlangen, Germany were released recently.
SpectraScience Inc reschedules endoscopy workshops in Germany due to high demand
M2 - Mon Apr 29, 9:00AM CDT
Medical device company SpectraScience Inc (OTCQB:SCIE) stated on Friday that its endoscopy workshop, featuring the WavSTAT4, has been rescheduled to a later date and venue.
SpectraScience Rescheduling Workshops Due to High Demand
Marketwire - Fri Apr 26, 8:00AM CDT
SpectraScience, Inc. (OTCQB: SCIE) announced today that the Company's first in a series of endoscopy workshops featuring the WavSTAT4, which was originally scheduled for April 25, 2013 in Erlangen, Germany, has been rescheduled. Greater than expected demand has resulted in a need to reschedule the entire series of workshops to add additional dates and insure the venue can accommodate larger workshop size.
SpectraScience and PENTAX Medical Announce Expanded Distribution of WavSTAT4 Optical Biopsy System in Europe
Business Wire - Wed Apr 10, 4:00AM CDT
SpectraScience, Inc. (OTCQB:SCIE), a San Diego-based medical device company and PENTAX Europe GmbH (PENTAX Medical herein after) jointly announce that they have agreed on expanded distribution of the WavSTAT4 Optical Biopsy System in Europe. Increased deployments of the WavSTAT4 system is expected in the PENTAX Medical fiscal year (April 2013 - March 2014).
SpectraScience Schedules Business Update Conference Call
Marketwire - Thu Mar 28, 4:00PM CDT
SpectraScience, Inc. (OTCQB: SCIE) today announced that the Company will hold a conference call at 4:30 p.m. Eastern (1:30 p.m. Pacific) on April 5th to provide an update on its business.
SpectraScience and PENTAX Showcase WaveSTAT4 Optical Biopsy System at Arab Health 2013
Marketwire - Wed Jan 30, 8:02AM CST
SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that in continuation of its distribution and sales efforts in Europe and the Middle East it is demonstrating its WavSTAT4 Optical Biopsy System at the 38th Annual Arab Health 2013 Exhibition and Congress. The Exhibition is taking place January 28th through 31st, 2013 in Dubai, United Arab Emirates. The WavSTAT4 Optical Biopsy System is available for demonstration at the PENTAX Europe booth at the Exhibition.
SpectraScience Announces Business Update Conference Call
GlobeNewswire - Tue Aug 19, 3:01PM CDT
SpectraScience, Inc. (OTCQB:SCIE) today announced the Company will hold a conference call at 4:30 p.m. Eastern (1:30 p.m. Pacific) on August 26, 2014 to provide an update on its business.
Volvo completes divestiture of Volvo Rents for USD1.1bn
M2 - Tue Feb 04, 6:02AM CST
Volvo AB (STO: VOLVA), based in Sweden, announced on Monday that its divestiture of Volvo Rents was completed on 31 January 2014.
SpectraScience Announces Commencement of Pan-European MORDIS Evaluation on WavSTAT4
GlobeNewswire - Mon Aug 05, 8:00AM CDT
SpectraScience, Inc. (OTCQB:SCIE), a San Diego-based medical device company, announced today that it has begun submission of its protocol to participating institutions for the MORDIS (MOdified Resect and DIScard) evaluation. The evaluation, which will be conducted at eight sites across Europe, brings together the foremost gastroenterologists in each of the respective nations to once again validate the clinical efficacy of the WavSTAT4 Optical Biopsy System.
SpectraScience Inc anticipates Q2 2013 revenues of USD120,000
M2 - Fri Jun 28, 7:31AM CDT
Medical device company SpectraScience Inc (OTCQB:SCIE) said on Thursday that it expects to generate revenues of approximately USD120,000 for its Q2 ending 30 June 2013.
SpectraScience Announces Q2 2013 Revenue
Marketwire - Thu Jun 27, 8:01AM CDT
SpectraScience, Inc. (OTCQB: SCIE), a San Diego-based medical device company, today announced it expects to recognize revenue of approximately $120,000 for its second quarter ending June 30, 2013.
SpectraScience, Inc. Announces Minimum Purchase Agreement With PENTAX Medical
Marketwire - Mon Jun 24, 8:01AM CDT
SpectraScience, Inc. (OTCQB: SCIE) announced today that PENTAX Medical GmbH, the sales, marketing and distribution partner for the WavSTAT4 Optical Biopsy System in Europe, has finalized and signed the minimum purchase requirement Exhibit of the Distribution Agreement for their fiscal year ending March 2014.
SpectraScience, Inc. Announces WavSTAT Live Demonstration at GEEW in Brussels
Marketwire - Wed Jun 19, 8:00AM CDT
SpectraScience, Inc. (OTCQB: SCIE) announced today that its WavSTAT4 Optical Biopsy System is being demonstrated at the 31(st) annual Gastroenterology and Endotherapy European Workshop (GEEW) that is taking place from Monday, June 17, through Wednesday, June 19, 2013 at the Brussels Exhibition Centre Hall 10 and Auditorium 2000 in Brussels, Belgium.
SpectraScience, Inc. Announces Positive Results From Study by Dr. Helmut Neumann
Marketwire - Tue Jun 11, 8:02AM CDT
SpectraScience, Inc. (OTCQB: SCIE) announced today that results from a critical study conducted by Dr. Helmut Neumann, of the University of Elrangen - Nuremberg in Erlangen, Germany were released recently.
SpectraScience Inc reschedules endoscopy workshops in Germany due to high demand
M2 - Mon Apr 29, 9:00AM CDT
Medical device company SpectraScience Inc (OTCQB:SCIE) stated on Friday that its endoscopy workshop, featuring the WavSTAT4, has been rescheduled to a later date and venue.
SpectraScience Rescheduling Workshops Due to High Demand
Marketwire - Fri Apr 26, 8:00AM CDT
SpectraScience, Inc. (OTCQB: SCIE) announced today that the Company's first in a series of endoscopy workshops featuring the WavSTAT4, which was originally scheduled for April 25, 2013 in Erlangen, Germany, has been rescheduled. Greater than expected demand has resulted in a need to reschedule the entire series of workshops to add additional dates and insure the venue can accommodate larger workshop size.
SpectraScience and PENTAX Medical Announce Expanded Distribution of WavSTAT4 Optical Biopsy System in Europe
Business Wire - Wed Apr 10, 4:00AM CDT
SpectraScience, Inc. (OTCQB:SCIE), a San Diego-based medical device company and PENTAX Europe GmbH (PENTAX Medical herein after) jointly announce that they have agreed on expanded distribution of the WavSTAT4 Optical Biopsy System in Europe. Increased deployments of the WavSTAT4 system is expected in the PENTAX Medical fiscal year (April 2013 - March 2014).
SpectraScience Schedules Business Update Conference Call
Marketwire - Thu Mar 28, 4:00PM CDT
SpectraScience, Inc. (OTCQB: SCIE) today announced that the Company will hold a conference call at 4:30 p.m. Eastern (1:30 p.m. Pacific) on April 5th to provide an update on its business.
SpectraScience and PENTAX Showcase WaveSTAT4 Optical Biopsy System at Arab Health 2013
Marketwire - Wed Jan 30, 8:02AM CST
SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that in continuation of its distribution and sales efforts in Europe and the Middle East it is demonstrating its WavSTAT4 Optical Biopsy System at the 38th Annual Arab Health 2013 Exhibition and Congress. The Exhibition is taking place January 28th through 31st, 2013 in Dubai, United Arab Emirates. The WavSTAT4 Optical Biopsy System is available for demonstration at the PENTAX Europe booth at the Exhibition.
